Masashi Yoneda

Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

Shiro Yokohama, Masashi Yoneda, Masakazu Haneda et al. · Hepatology · 2004 · 459 citations · Full text

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

Plasma transforming growth factor‐β1 level and efficacy of α‐tocopherol in patients with non‐alcoholic steatohepatitis: a pilot study

Tsukasa Hasegawa, Masashi Yoneda, Kimihide Nakamura et al. · Alimentary Pharmacology & Therapeutics · 2001 · 405 citations

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Sumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima et al. · Journal of Gastroenterology · 2015 · 326 citations · Full text

Metabolic Associated Steatohepatitis, Hepatology, Metabolic Associated Steatotic Liver Disease +10

Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Sumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima et al. · Hepatology Research · 2015 · 204 citations